Hepatitis C testing is a two-step process: a simple blood test checks whether you’ve ever been exposed to the virus, and if that comes back positive, a second test determines whether you have an active infection right now. Most adults should be screened at least once in their lifetime, and the whole process can often be completed from a single blood draw.
Step One: The Antibody Test
The first test looks for antibodies your immune system produced in response to the hepatitis C virus. This is a standard blood draw, typically from your arm, and results usually come back within a few days. A negative result means no antibodies were detected, and in most cases, no further testing is needed.
A positive (reactive) antibody result does not mean you currently have hepatitis C. It means your body encountered the virus at some point. Roughly 20 to 25 percent of people who get infected clear the virus on their own, and their antibodies stick around permanently even though the infection is gone. A positive antibody test can also reflect a past infection that was successfully treated, or in rare cases, a false positive. That’s why the second test exists.
Step Two: The RNA Test
If your antibody test is reactive, the next step is an RNA test (sometimes called a nucleic acid test). This one looks for the actual genetic material of the virus in your blood. If hepatitis C RNA is detected, you have a current, active infection. If no RNA is detected, you don’t have an active infection, and the earlier antibody result reflects either a cleared past infection or a false positive.
Many labs now use what’s called “reflex testing.” When you order a hepatitis C test, the lab automatically runs the RNA test on the same blood sample if the antibody result is positive. This means you don’t need to come back for a second blood draw, and it speeds up the path to a definitive answer. If you’re ordering testing yourself or through a primary care visit, it’s worth confirming that reflex testing is included. Quest Health, for example, offers a combined antibody-plus-confirmation test for about $68 out of pocket, with the RNA confirmation included at no extra charge if the antibody test is reactive.
One Unusual Scenario Worth Knowing
There’s a fourth combination of results that catches people off guard: a negative antibody test with a positive RNA result. This points to a very recent infection, likely acquired in the past three months. Your body hasn’t had time to produce detectable antibodies yet, but the virus itself is already circulating. This pattern is most relevant if you’re being tested shortly after a known exposure.
Rapid Fingerstick Tests
Point-of-care rapid tests use a fingerstick drop of blood and can deliver an antibody result in about 20 minutes. These are commonly offered at community health centers, harm reduction programs, and mobile testing events. They’re convenient but slightly less sensitive than standard lab-based tests, particularly when using whole blood from a fingerstick. One large multicenter study found that rapid fingerstick tests detected antibodies in about 87 to 91 percent of people who were truly positive, compared with 97 percent or higher when the same rapid test was performed on plasma or serum in a lab setting. Specificity (correctly identifying people who don’t have the virus) was consistently high at 98 percent or above across all sample types.
If a rapid test comes back reactive, you’ll still need a lab-based RNA test to confirm whether the infection is active. If it comes back negative but you had a recent exposure, a follow-up lab test may still be warranted because of the sensitivity gap with fingerstick samples.
When Tests Can Detect the Virus
Timing matters. If you’re testing after a specific exposure, the type of test determines how soon it can pick up the infection. RNA tests can detect the virus in your blood within one to two weeks of infection. Antibody tests take significantly longer. Antibodies typically become detectable around 50 to 60 days after infection, though the range stretches from 20 to 150 days. That gap between when RNA becomes detectable and when antibodies appear is called the window period.
If you’re testing because of a known exposure (a needlestick, shared injection equipment, or another specific event), an RNA test at four to six weeks is the most reliable early option. An antibody test taken too soon after exposure can come back falsely negative simply because your body hasn’t produced enough antibodies yet.
Understanding Your Results
Here’s how the four possible result combinations break down:
- Antibody negative, RNA negative: No infection. You have not been exposed to hepatitis C.
- Antibody positive, RNA positive: Active hepatitis C infection. You currently carry the virus and are eligible for treatment.
- Antibody positive, RNA negative: You were exposed at some point, but the virus is no longer in your system. This happens after spontaneous clearance or successful treatment. No treatment is needed.
- Antibody negative, RNA positive: Very early (acute) infection, likely within the past three months. Your immune system hasn’t produced detectable antibodies yet.
What Happens After a Positive Diagnosis
If both your antibody and RNA tests are positive, confirming an active infection, your provider will evaluate you for treatment. In the past, a genotype test (identifying which strain of the virus you carry) was a required next step because different strains required different medications. That’s largely changed. Current treatment regimens work across all genotypes, so genotyping is no longer required for most people starting treatment for the first time who don’t have significant liver scarring. If you do have cirrhosis or have been treated unsuccessfully before, genotype testing may still guide which specific regimen works best.
Your provider will also assess your liver health, typically through blood tests that estimate the degree of scarring and sometimes an imaging study. This helps determine the urgency and duration of treatment. Modern antiviral treatments cure hepatitis C in over 95 percent of cases, usually with eight to twelve weeks of oral medication.
Who Should Get Tested
Current guidelines recommend that every adult aged 18 and older be screened for hepatitis C at least once. Pregnant individuals should be tested during each pregnancy. Beyond universal screening, repeat or more frequent testing is appropriate if you inject drugs (even if only once in the past), received a blood transfusion or organ transplant before 1992, are on long-term hemodialysis, have HIV, or had a known exposure to hepatitis C-positive blood. Many people with hepatitis C have no symptoms for years or even decades, which is why screening based on risk factors alone misses a significant number of infections.